Blue Cross Blue Shield of Michigan GLP-1 Coverage Changes Explained

Starting August 1, 2024, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN) will modify their coverage for GLP-1 receptor agonists, including popular weight loss medications like Saxenda®, Wegovy®, and Zepbound®. By January 1, 2025, coverage for these medications will end, impacting many patients.

To help navigate these changes, Restorative Compounding Pharmacy + Wellness offers affordable, high-quality compounded semaglutide and tirzepatide. Our solutions ensure effective treatment without the high costs, tailored to your specific needs.